EPA approves PDI’s Sani-Cloth Bleach Wipes for use against SARS-CoV-2

January 12, 2021 – PDI (Woodcliff Lake, NJ) announced that the FDA has approved the company’s claim that Sani-Cloth Bleach wipes are effective against SARS-CoV-2, the virus that causes COVID-19.

This EPA approval has expanded the label claims for Sani-Cloth Bleach wipes (EPA Reg No. 9480-8) to include deactivation of SARS-CoV-2 after one minute of contact time on hard, nonporous surfaces.

Before a product can legally make efficacy claims against a particular pathogen, the claim must be approved by the EPA based on a thorough review of scientific data. According to the data provided by PDI Healthcare, the Sani-Cloth Bleach wipes caused a 3-log reduction against the SARS-CoV-2 virus, which meets the EPA’s efficacy requirements. Prior to receiving approval for this claim, Sani-Cloth Bleach wipes were included on EPA’s List N: Disinfectants for Coronavirus (COVID-19).

Learn More